Viome Life Sciences, Inc.

Viome Life Sciences, Inc. is a biotechnology company founded in 2016 by Naveen Jain, Momo Vuyisich, and Guruduth Banavar, with its headquarters located in Bellevue, Washington. Originally emerging from BlueDot, an innovation factory launched by Jain to commercialize government research, the company was initially established as Bluespin with a focus on the early detection of diseases. The company officially changed its name to Viome in 2016 and was formally established in Bellevue on October 1, 2016. In July 2021, the entity underwent a corporate rebrand to Viome Life Sciences to reflect its expansion into clinical diagnostics and therapeutics. During this transition, the business was strategically divided into two distinct arms: Viome Consumer Services with brand name Viome, which manages wellness products such as gut health tests and supplements, and Viome Health Sciences, which focuses on research and development for chronic diseases and cancer. Business/Product Breakdown Viome Life Sciences, Inc. operates a platform that utilizes metatranscriptomic sequencing technology to analyze microbial activity and human gene expression. Through its consumer division, the company provides at-home testing kits?including the Gut Intelligence and Full Body Intelligence tests?that analyze stool, blood, or saliva samples to map biological data points. An artificial intelligence engine then processes this data to generate personalized nutritional recommendations and high-precision supplements, such as vitamins, minerals, and probiotics, specifically tailored to an individual's biochemical needs. The health sciences division focuses on the discovery of biomarkers for the early detection of life-threatening conditions. This clinical arm develops diagnostic tools, such as the CancerDetect test for oral and throat cancers, which received Breakthrough Device Designation from the FDA. The company's methodology is based on the premise that chronic inflammation and disease progression can be mitigated by understanding and managing the molecular interactions between the human microbiome and the host.